Posts filed under: Orthopedic Biomaterials

These newly introduced products join Trabexus EB, which first received 510(k) clearance in 2015. TRABEXUS EB is a self-setting, gradually resorbable, calcium phosphate matrix enhanced with partially demineralized allograft particles....
Continue Reading →
Bone graft substitutes are widely used in a variety of indications, including dental, spine, trauma, large joint, foot & ankle, craniomaxillofacial, and oncology....
Continue Reading →
  • Bone growth medical product
Firm wants data on best dosage of controversial bone-growth product. ...
Continue Reading →
The U.S. orthopedic biomaterials market is expected to increase to exceed $4.5 billion by 2023...
Continue Reading →
By Payam Moghimi-Bidhendi and Jesse Spicer – iData Research Inc. The European orthopedic biomaterials market is broadly driven by the aging population and for being an attractive alternative for patients looking to avoid surgical implantation of permanent devices or hardware....
Continue Reading →
This price deterioration will have a negative impact on the market, as it may not be economically feasible for certain competitors to penetrate the European market with low average selling prices...
Continue Reading →
NovaBone Products, a leading biologics medical device company, recently announced the addition of NovaBone IRM and NovaBone IRM MacroPOR to its portfolio of biologically active bone graft substitutes....
Continue Reading →
By Payam Moghimi-Bidhendi and Kamran Zamanian, Ph.D, iData Research Inc Introduction The U.S. orthopedic biomaterials market has become an attractive alternative for patients looking to avoid surgical implantation of permanent devices or hardware. Orthopedic surgeries are generally complicated, multi-stage procedures...
Continue Reading →
SIRAKOSS' patent portfolio encompasses advanced synthetic bone graft technologies which form the company’s product pipeline designed to address the significant clinical need for a fully-synthetic, standalone bone void filler....
Continue Reading →
The Vu a•POD Prime NanoMetalene System features a zero-profile, standalone anterior lumbar interbody device that can be configured in a variety of footprint and lordosis combinations to accommodate an individual patient’s pathology....
Continue Reading →

Thank you!

CLOSE

Login

Sign Up

Already have an account? Sign in

×